https://medicaex.com/businesswire/barry-mirrer-head-of-quality-assurance-prometrika-has-earned-cipp-e-certification-2/ 2022-11-02T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/PROMETRIKA_logo_RGB-Xx4LGO.jpeg https://medicaex.com/businesswire/earlier-predictions-in-covid-19-infection-rates-with-wearable-device-data-and-careevolutions-research-platform-2/ 2022-11-02T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareEvolutionLogo_2c_28229-1M073p.jpeg https://medicaex.com/businesswire/earlier-predictions-in-covid-19-infection-rates-with-wearable-device-data-and-careevolutions-research-platform/ 2022-11-02T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareEvolutionLogo_2c_28229-KcxKja.jpeg https://medicaex.com/businesswire/global-self-testing-kits-market-trends-and-forecasts-report-2019-2021-2022-2027-featuring-major-manufacturers-abbott-acon-laboratories-inc-roche-assure-tech-and-advacare-pharma-research/ 2022-11-02T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-wQ4inA.jpeg https://medicaex.com/businesswire/barry-mirrer-head-of-quality-assurance-prometrika-has-earned-cipp-e-certification/ 2022-11-02T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/PROMETRIKA_logo_RGB-p2JPKf.jpeg https://medicaex.com/businesswire/new-research-in-over-3700-patients-treated-with-worlds-first-and-only-swallowable-gastric-balloon-program-reveals-weight-loss-of-over-14-total-body-weight-4/ 2022-11-02T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/All_products_horizontal_HD_ivory_28129-BnaIGb.jpeg https://medicaex.com/businesswire/carta-healthcare-secures-20-million-series-b-funding-to-help-additional-health-systems-improve-patient-care-amid-challenging-global-economy-pandemic-turbulence-and-downturn-in-vc-funding/ 2022-11-02T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Carta-Healthcare_Logo-Shasta-ba60jJ.jpeg https://medicaex.com/businesswire/instem-unveils-new-additions-to-its-leading-computational-toxicology-software-suite-2/ 2022-11-02T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/INSTEM-logo-JPG-uk-201021_28429-kTJzyO.jpeg https://medicaex.com/businesswire/new-aco-compare-4-0-from-innovaccer-can-help-acos-lower-costs-and-increase-care-quality/ 2022-11-02T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Innovaccer_Logo-74XL4c.jpeg https://medicaex.com/businesswire/new-research-in-over-3700-patients-treated-with-worlds-first-and-only-swallowable-gastric-balloon-program-reveals-weight-loss-of-over-14-total-body-weight-2/ 2022-11-02T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/All_products_horizontal_HD_ivory_28129-8BOYox.jpeg https://medicaex.com/businesswire/global-acute-cholecystitis-market-report-2022-rising-instances-of-gall-bladder-stone-issues-fueling-growth-researchandmarkets-com/ 2022-11-02T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KRvyJF.jpeg https://medicaex.com/businesswire/pharma-rd-outsourcing-global-market-report-2022-paradigm-shift-towards-virtual-clinical-trials-reshaping-sector-researchandmarkets-com/ 2022-11-02T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-hXbPMY.jpeg https://medicaex.com/businesswire/instem-unveils-new-additions-to-its-leading-computational-toxicology-software-suite/ 2022-11-02T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/INSTEM-logo-JPG-uk-201021_28429-ratUS1.jpeg https://medicaex.com/businesswire/walgreens-announces-agreement-in-principle-for-multi-state-opioid-settlement-framework/ 2022-11-02T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Walgreens_CW-RGB-Z1vCTh.jpeg https://medicaex.com/businesswire/healthtap-launches-eval360-for-health-plans-to-offer-members-comprehensive-primary-care-evaluations-for-better-outcomes-and-lower-costs/ 2022-11-02T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/DuoTone_Logo-2022-filUej.jpeg https://medicaex.com/businesswire/new-research-in-over-3700-patients-treated-with-worlds-first-and-only-swallowable-gastric-balloon-program-reveals-weight-loss-of-over-14-total-body-weight/ 2022-11-02T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/All_products_horizontal_HD_ivory_28129-cTit99.jpeg https://medicaex.com/businesswire/u-s-teleradiology-market-report-2022-to-2027-featuring-koninklijke-philip-radiology-partners-and-teleradiology-solutions-among-others-researchandmarkets-com/ 2022-11-02T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-vMsqKC.jpeg https://medicaex.com/businesswire/renovion-announces-first-patient-enrolled-in-phase-2-clinical-study-evaluating-arina-1-for-the-treatment-of-non-cf-bronchiectasis-2/ 2022-11-02T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Renovion-pxgED0.jpeg https://medicaex.com/businesswire/pathai-to-present-recent-advances-in-applying-ai-powered-pathology-towards-liver-disease-at-the-american-association-for-the-study-of-liver-diseases-aasld-2022-liver-meeting-3/ 2022-11-02T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/PathAI_logo-8FuUr6.jpeg https://medicaex.com/businesswire/abcelleras-first-program-with-regeneron-in-multi-target-collaboration-advances-in-preclinical-development-3/ 2022-11-02T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-9kd98J.jpeg https://medicaex.com/businesswire/prescription-drug-safety-network-reached-more-than-22000-students-with-prescription-drug-safety-digital-education-during-2021-22-school-year-2/ 2022-11-02T13:12:12+00:00 https://medicaex.com/businesswire/evolus-to-participate-in-november-conferences/ 2022-11-02T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/LOGO-o2phcn.jpeg https://medicaex.com/businesswire/abcelleras-first-program-with-regeneron-in-multi-target-collaboration-advances-in-preclinical-development-2/ 2022-11-02T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-4TYio3.jpeg https://medicaex.com/businesswire/icon-exchange-launches-all-in-one-credentialing-wallet-for-healthcare-professionals/ 2022-11-02T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-iconExchange-Final-JLgg5F.jpeg https://medicaex.com/businesswire/pointclickcare-celebrates-its-10th-annual-user-conference-in-las-vegas/ 2022-11-02T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/PointClickCareLogoCMYK-PKIBfV.jpeg https://medicaex.com/businesswire/pathai-to-present-recent-advances-in-applying-ai-powered-pathology-towards-liver-disease-at-the-american-association-for-the-study-of-liver-diseases-aasld-2022-liver-meeting-2/ 2022-11-02T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/PathAI_logo-gaSDyS.jpeg https://medicaex.com/businesswire/floridas-palm-vascular-centers-is-the-first-healthcare-organization-to-install-xenfi-the-recently-announced-wireless-medical-ecosystem-from-xenter/ 2022-11-02T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Robert_E._Beasley2C_MD_28Palm_Vascular_Centers292C_11-2022-NE5TT1.jpeg https://medicaex.com/businesswire/24-month-data-from-surmodics-transcend-trial-presented-at-viva-2022-conference/ 2022-11-02T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/press_release_logo-f4pcd2.jpeg https://medicaex.com/businesswire/prescription-drug-safety-network-reached-more-than-22000-students-with-prescription-drug-safety-digital-education-during-2021-22-school-year/ 2022-11-02T13:12:05+00:00 https://medicaex.com/businesswire/advancing-health-equity-improving-health-outcomes-for-all-could-save-u-s-3-8-trillion/ 2022-11-02T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/PFCD_Logo-6tvoFL.jpeg https://medicaex.com/businesswire/pathai-to-present-recent-advances-in-applying-ai-powered-pathology-towards-liver-disease-at-the-american-association-for-the-study-of-liver-diseases-aasld-2022-liver-meeting/ 2022-11-02T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/PathAI_logo-F73C3M.jpeg https://medicaex.com/businesswire/abcelleras-first-program-with-regeneron-in-multi-target-collaboration-advances-in-preclinical-development/ 2022-11-02T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-BGCQ0N.jpeg https://medicaex.com/businesswire/renovion-announces-first-patient-enrolled-in-phase-2-clinical-study-evaluating-arina-1-for-the-treatment-of-non-cf-bronchiectasis/ 2022-11-02T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Renovion-0l52Kg.jpeg https://medicaex.com/businesswire/catapult-health-adds-anxiety-screening-to-its-virtualcheckup-solution-to-better-assess-hidden-mental-health-issues-impacting-the-workforce/ 2022-11-02T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Man_with_Umbrella_Photo-bW29jb.jpeg https://medicaex.com/businesswire/orsobio-announces-acquisition-of-lxr-inverse-agonist-program-for-treatment-of-severe-dyslipidemias-from-phenex-pharmaceuticals-2/ 2022-11-02T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-Yt8ujI.jpeg https://medicaex.com/businesswire/disposable-bronchoscopes-market-report-2022-growing-demand-for-same-day-surgeries-minimally-invasive-procedures-bolsters-sector-researchandmarkets-com/ 2022-11-02T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-weUvjg.jpeg https://medicaex.com/businesswire/orsobio-acquires-acmsd-inhibitor-program-to-address-mitochondrial-dysfunction-from-mitobridge-an-astellas-company-2/ 2022-11-02T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-PNythP.jpeg https://medicaex.com/businesswire/orsobio-acquires-phase-2-ready-selective-acc2-inhibitor-from-shionogi-co-ltd-for-the-treatment-of-type-2-diabetes-2/ 2022-11-02T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-yInm37.jpeg https://medicaex.com/businesswire/ntt-research-develops-closed-loop-control-of-innervated-tissue-2/ 2022-11-02T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/NTTResearch_Symbol-8laosj.jpeg https://medicaex.com/businesswire/lantern-pharma-management-to-present-at-upcoming-investor-conferences-in-q4/ 2022-11-02T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lantern_Logo_Stacked-E3yz3Z.jpeg https://medicaex.com/businesswire/inscopix-expands-cloud-based-ideas-platform-for-individual-lab-use-2/ 2022-11-02T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inscopix_Logo_JPG-Iehp18.jpeg https://medicaex.com/businesswire/inogen-announces-third-quarter-2022-financial-results-2/ 2022-11-02T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inogen_Logo_300_DPI-0sMTAR.jpeg https://medicaex.com/businesswire/ntt-research-develops-closed-loop-control-of-innervated-tissue/ 2022-11-02T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/NTTResearch_Symbol-YaN6dR.jpeg https://medicaex.com/businesswire/hologic-announces-contract-with-barda-to-support-ivd-approval-of-covid-assays/ 2022-11-02T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Hologic_Main_Logo_Small_White_cropped-T87Kdl.jpeg https://medicaex.com/businesswire/inogen-announces-third-quarter-2022-financial-results/ 2022-11-02T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inogen_Logo_300_DPI-3ftoos.jpeg https://medicaex.com/businesswire/viz-ai-partners-with-us2-ai-to-deliver-ai-enabled-echocardiography-decision-support-with-the-viz-platform/ 2022-11-02T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Viz_Us2.ai_logo-dUL6qk.jpeg https://medicaex.com/businesswire/lensar-to-report-third-quarter-2022-financial-results-on-wednesday-november-9-2022/ 2022-11-02T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/LNSR_Logo-lHjqKX.jpeg https://medicaex.com/businesswire/blaze-bioscience-announces-enrollment-is-complete-on-its-pivotal-phase-2-3-trial-of-tozuleristide-and-the-canvastm-imaging-system-in-pediatric-central-nervous-system-tumors/ 2022-11-02T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Blaze_Bioscience_Brand_Identity_FINAL_28Solid29-01-MFw5rs.jpeg https://medicaex.com/businesswire/inscopix-expands-cloud-based-ideas-platform-for-individual-lab-use/ 2022-11-02T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inscopix_Logo_JPG-Ee6kPi.jpeg https://medicaex.com/businesswire/orsobio-announces-exclusive-license-to-intellectual-property-relating-to-mitochondrial-protonophores-for-the-treatment-of-severe-metabolic-disorders-2/ 2022-11-02T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-SfbBTx.jpeg https://medicaex.com/businesswire/bluestar-genomics-presents-positive-results-from-validation-study-in-pancreatic-cancer-detection-at-american-pancreatic-association-apa-annual-meeting/ 2022-11-02T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bluestar_Logo_RGB_150-hFMdyj.jpeg https://medicaex.com/businesswire/orsobio-acquires-phase-2-ready-selective-acc2-inhibitor-from-shionogi-co-ltd-for-the-treatment-of-type-2-diabetes/ 2022-11-02T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-RtP4IK.jpeg https://medicaex.com/businesswire/orsobio-announces-acquisition-of-lxr-inverse-agonist-program-for-treatment-of-severe-dyslipidemias-from-phenex-pharmaceuticals/ 2022-11-02T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-enQB8b.jpeg https://medicaex.com/businesswire/orsobio-acquires-acmsd-inhibitor-program-to-address-mitochondrial-dysfunction-from-mitobridge-an-astellas-company/ 2022-11-02T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-kFNLq0.jpeg https://medicaex.com/businesswire/orsobio-announces-exclusive-license-to-intellectual-property-relating-to-mitochondrial-protonophores-for-the-treatment-of-severe-metabolic-disorders/ 2022-11-02T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-lKAGwr.jpeg https://medicaex.com/businesswire/omnicell-announces-financial-results-for-third-quarter-2022-2/ 2022-11-02T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/01_omnicell_lockup_horizontal_green_rgb-qD7wAj.jpeg https://medicaex.com/businesswire/omnicell-announces-financial-results-for-third-quarter-2022/ 2022-11-02T12:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/01_omnicell_lockup_horizontal_green_rgb-GG2hHv.jpeg https://medicaex.com/businesswire/docgo-announces-90-million-line-of-credit-with-citibank-n-a/ 2022-11-02T12:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Logo_1-jzV8jK.jpeg https://medicaex.com/businesswire/caredx-demonstrates-power-of-allosure-and-digital-health-transplant-solutions-at-american-society-of-nephrology-kidney-week/ 2022-11-02T11:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareDx_Logo-ouwUnm.jpeg https://medicaex.com/businesswire/horizon-therapeutics-plc-reports-third-quarter-2022-financial-results-increases-full-year-2022-net-sales-and-adjusted-ebitda-guidance-increases-tepezza-and-krystexxa-peak-annual-net-sales-expectatio-2/ 2022-11-02T11:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Horizon_Logo_Full-Color_RGB_Registered_Logo-2FKrk9.jpeg https://medicaex.com/businesswire/charles-river-laboratories-announces-third-quarter-2022-results-3/ 2022-11-02T11:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-D18FaS.jpeg https://medicaex.com/businesswire/precision-biosciences-to-report-third-quarter-2022-financial-results-on-november-8-2022-2/ 2022-11-02T11:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Precision_BioSciences_logo-60dStg.jpeg https://medicaex.com/businesswire/u-s-food-and-drug-administration-approves-vemlidy-tenofovir-alafenamide-for-treatment-of-chronic-hepatitis-b-virus-infection-in-pediatric-patients-2/ 2022-11-02T11:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/GCP_Primarylarge_1-NPAqiu.jpeg https://medicaex.com/businesswire/outlook-on-the-big-data-analytics-in-healthcare-global-market-to-2028-rising-inclination-toward-cloud-based-analytics-solutions-presents-opportunities-researchandmarkets-com/ 2022-11-02T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-aVFKXB.jpeg https://medicaex.com/businesswire/908-devices-to-participate-in-upcoming-investor-conferences-2/ 2022-11-02T11:12:11+00:00 https://medicaex.com/businesswire/omniab-inc-to-ring-nasdaq-stock-market-opening-bell/ 2022-11-02T11:12:11+00:00 https://medicaex.com/businesswire/redwire-launching-upgraded-3d-bioprinter-to-space-station-to-investigate-new-treatment-to-aid-military-service-members-expands-crop-production-research-and-materials-testing-on-orbit/ 2022-11-02T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/redwire-logo-horizontal-black-red_28129-dQ0ynb.jpeg https://medicaex.com/businesswire/sonendo-inc-to-present-at-the-stifel-2022-healthcare-conference/ 2022-11-02T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sonendo-Logo-1920x1080-Color-DfIWen.jpeg https://medicaex.com/businesswire/charles-river-laboratories-announces-third-quarter-2022-results-2/ 2022-11-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-JbILNI.jpeg https://medicaex.com/businesswire/908-devices-to-participate-in-upcoming-investor-conferences/ 2022-11-02T11:12:09+00:00 https://medicaex.com/businesswire/antibe-closes-previously-announced-strategic-sale-of-citagenix-subsidiary/ 2022-11-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANTIBE-logo-RGB-GzJdMk.jpeg https://medicaex.com/businesswire/global-hemoglobin-testing-market-to-reach-3-2-billion-by-2027-researchandmarkets-com/ 2022-11-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-phwl0q.jpeg https://medicaex.com/businesswire/worldwide-insulin-pumps-industry-to-2028-featuring-tandem-diabetes-care-f-hoffmann-la-roche-ypsomed-and-valeritas-among-others-researchandmarkets-com/ 2022-11-02T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cL49Nz.jpeg https://medicaex.com/businesswire/owens-minor-reports-third-quarter-2022-financial-results/ 2022-11-02T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/O26M_LogoTM_hi-res-p8nYvz.jpeg https://medicaex.com/businesswire/precision-biosciences-to-report-third-quarter-2022-financial-results-on-november-8-2022/ 2022-11-02T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Precision_BioSciences_logo-AWdTea.jpeg https://medicaex.com/businesswire/xeris-biopharma-to-report-third-quarter-2022-financial-results-on-november-9-2022/ 2022-11-02T11:12:06+00:00 https://medicaex.com/businesswire/u-s-food-and-drug-administration-approves-vemlidy-tenofovir-alafenamide-for-treatment-of-chronic-hepatitis-b-virus-infection-in-pediatric-patients/ 2022-11-02T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/GCP_Primarylarge_1-pYTITT.jpeg https://medicaex.com/businesswire/horizon-therapeutics-plc-reports-third-quarter-2022-financial-results-increases-full-year-2022-net-sales-and-adjusted-ebitda-guidance-increases-tepezza-and-krystexxa-peak-annual-net-sales-expectatio/ 2022-11-02T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Horizon_Logo_Full-Color_RGB_Registered_Logo-v4erPQ.jpeg https://medicaex.com/businesswire/charles-river-laboratories-announces-third-quarter-2022-results/ 2022-11-02T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-i7UWuG.jpeg https://medicaex.com/businesswire/united-therapeutics-corporation-reports-third-quarter-2022-financial-results-2/ 2022-11-02T10:12:11+00:00 https://medicaex.com/businesswire/global-urinalysis-market-2022-2026-growing-adoption-of-point-of-care-urinalysis-provides-boost-to-sector-researchandmarkets-com/ 2022-11-02T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-s5PAST.jpeg https://medicaex.com/businesswire/live-pharmacy-next-expert-panel-predicts-future-of-medication-safety-affordability-personalization-2/ 2022-11-02T10:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/WoltersKluwer_CMYK-ol-duQFem.jpeg https://medicaex.com/businesswire/livanova-reports-third-quarter-2022-results-2/ 2022-11-02T10:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-7fSnUd.jpeg https://medicaex.com/businesswire/livanova-reports-third-quarter-2022-results/ 2022-11-02T10:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-iixF7x.jpeg https://medicaex.com/businesswire/censisai2-productivity-provides-actionable-intelligence-for-faster-better-decision-making-in-sterile-processing-departments/ 2022-11-02T10:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/A78A9709-SyKQ33.jpeg https://medicaex.com/businesswire/nurse-turnover-doubles-since-the-pandemic-and-half-report-feelings-of-burnout-according-to-new-report-from-vizient-vaya-workforce/ 2022-11-02T10:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vizient_Logo_V2-j4yWMr.jpeg https://medicaex.com/businesswire/transdermal-drug-delivery-market-analysis-2022-technological-advances-present-lucrative-opportunities-researchandmarkets-com/ 2022-11-02T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-9YoUFC.jpeg https://medicaex.com/businesswire/live-pharmacy-next-expert-panel-predicts-future-of-medication-safety-affordability-personalization/ 2022-11-02T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/WoltersKluwer_CMYK-ol-sLOxTS.jpeg https://medicaex.com/businesswire/united-therapeutics-corporation-reports-third-quarter-2022-financial-results/ 2022-11-02T10:12:04+00:00 https://medicaex.com/businesswire/cureapp-digital-therapeutic-app-for-hypertension-receives-insurance-coverage-sales-of-the-service-to-medical-institutions-across-japan-launch-on-september-1-3/ 2022-11-02T09:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/img_english-EnIkBO.jpeg https://medicaex.com/businesswire/cureapp-digital-therapeutic-app-for-hypertension-receives-insurance-coverage-sales-of-the-service-to-medical-institutions-across-japan-launch-on-september-1-2/ 2022-11-02T09:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/img_english-c4E9nZ.jpeg https://medicaex.com/businesswire/cureapp-digital-therapeutic-app-for-hypertension-receives-insurance-coverage-sales-of-the-service-to-medical-institutions-across-japan-launch-on-september-1/ 2022-11-02T09:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/img_english-1S7Jyc.jpeg https://medicaex.com/businesswire/innate-pharma-to-participate-in-upcoming-investor-conferences/ 2022-11-02T06:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/INNATEvertnoirDS-GlYui9.jpeg https://medicaex.com/businesswire/arcturus-announces-collaboration-with-csl-to-develop-and-commercialize-self-amplifying-mrna-vaccines-2/ 2022-11-01T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/arcturus-logo-blueback-YfNEjp.jpeg https://medicaex.com/businesswire/arcturus-announces-collaboration-with-csl-to-develop-and-commercialize-self-amplifying-mrna-vaccines/ 2022-11-01T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/arcturus-logo-blueback-sfZDwY.jpeg https://medicaex.com/businesswire/dr-frank-greenway-to-present-data-from-the-light-up-study-with-gelesis-oral-hydrogel-treatment-gs200-at-obesity-week/ 2022-11-01T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/4769212cGreenway_PR_V2_en-1-Huv5MM.jpeg https://medicaex.com/businesswire/veracyte-announces-three-abstracts-to-be-presented-at-sitc-2022-annual-meeting-2/ 2022-11-01T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Veracyte_RGB_LRG_H_registered-uWkvm0.jpeg https://medicaex.com/businesswire/quanterix-third-quarter-2022-earnings-conference-call-2/ 2022-11-01T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Quanterix_Logo-QjM07y.jpeg https://medicaex.com/businesswire/immunogen-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-11-01T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/imgnlogo-T2RD81.jpeg https://medicaex.com/businesswire/igc-reports-financial-results-for-second-fiscal-quarter-ended-sept-30-2022-2/ 2022-11-01T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/IGC_Logo-C6cu8o.jpeg https://medicaex.com/businesswire/veracyte-announces-three-abstracts-to-be-presented-at-sitc-2022-annual-meeting/ 2022-11-01T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Veracyte_RGB_LRG_H_registered-MEIlWY.jpeg https://medicaex.com/businesswire/ryam-announces-third-quarter-2022-results/ 2022-11-01T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/RYAM_Logo-ftCTbE.jpeg https://medicaex.com/businesswire/quanterix-third-quarter-2022-earnings-conference-call/ 2022-11-01T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Quanterix_Logo-EzkDsv.jpeg https://medicaex.com/businesswire/immunogen-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-11-01T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/imgnlogo-hJSa35.jpeg https://medicaex.com/businesswire/igc-reports-financial-results-for-second-fiscal-quarter-ended-sept-30-2022/ 2022-11-01T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/IGC_Logo-GCryIl.jpeg https://medicaex.com/businesswire/mckesson-corporation-reports-fiscal-2023-second-quarter-results-and-raises-full-year-guidance-4/ 2022-11-01T20:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/McKesson_Logo-jI7ddl.jpeg https://medicaex.com/businesswire/michael-aldridge-seasoned-biotech-executive-appointed-ceo-of-focal-medical-3/ 2022-11-01T20:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Michael_Aldridge_CU-yR9p4J.jpeg https://medicaex.com/businesswire/exelixis-and-sairopa-establish-exclusive-clinical-development-collaboration-and-option-agreement-to-develop-adu-1805-a-potentially-best-in-class-monoclonal-antibody-targeting-sirp%ce%b1-2/ 2022-11-01T20:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/exelixis_id_rgb_2c-qJae9q.jpeg https://medicaex.com/businesswire/exelixis-and-cybrexa-therapeutics-establish-exclusive-collaboration-providing-exelixis-the-right-to-acquire-cbx-12-a-potential-first-in-class-peptide-drug-conjugate-of-exatecan-2/ 2022-11-01T20:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/exelixis_id_rgb_2c-xbbDNn.jpeg https://medicaex.com/businesswire/exelixis-announces-third-quarter-2022-financial-results-and-provides-corporate-update-2/ 2022-11-01T20:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/exelixis_id_rgb_2c-0KtvMD.jpeg https://medicaex.com/businesswire/cpsi-announces-third-quarter-2022-results/ 2022-11-01T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/CPSINew2021-mJrNfT.jpeg https://medicaex.com/businesswire/ambrx-biopharma-inc-appoints-daniel-oconnor-as-chief-executive-officer/ 2022-11-01T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ambrx_Logo-NRJPKA.jpeg https://medicaex.com/businesswire/mckesson-corporation-reports-fiscal-2023-second-quarter-results-and-raises-full-year-guidance-3/ 2022-11-01T20:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/McKesson_Logo-Yg3kDj.jpeg https://medicaex.com/businesswire/michael-aldridge-seasoned-biotech-executive-appointed-ceo-of-focal-medical-2/ 2022-11-01T20:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Michael_Aldridge_CU-cPMnQW.jpeg https://medicaex.com/businesswire/performant-financial-corporation-to-report-third-quarter-2022-earnings-on-november-8-2022/ 2022-11-01T20:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Performant_Logo_Full_Color-02MRAY.jpeg https://medicaex.com/businesswire/atricure-reports-third-quarter-2022-financial-results/ 2022-11-01T20:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/AtriCure_logo_1-color_RBG_Web_010218-h2PQG9.jpeg https://medicaex.com/businesswire/mckesson-corporation-reports-fiscal-2023-second-quarter-results-and-raises-full-year-guidance-2/ 2022-11-01T20:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/McKesson_Logo-C8TPGN.jpeg https://medicaex.com/businesswire/exelixis-and-sairopa-establish-exclusive-clinical-development-collaboration-and-option-agreement-to-develop-adu-1805-a-potentially-best-in-class-monoclonal-antibody-targeting-sirp%ce%b1/ 2022-11-01T20:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/exelixis_id_rgb_2c-RcD1fW.jpeg https://medicaex.com/businesswire/exelixis-and-cybrexa-therapeutics-establish-exclusive-collaboration-providing-exelixis-the-right-to-acquire-cbx-12-a-potential-first-in-class-peptide-drug-conjugate-of-exatecan/ 2022-11-01T20:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/exelixis_id_rgb_2c-3vwZ4T.jpeg https://medicaex.com/businesswire/exelixis-announces-third-quarter-2022-financial-results-and-provides-corporate-update/ 2022-11-01T20:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/exelixis_id_rgb_2c-y867Ka.jpeg https://medicaex.com/businesswire/mckesson-corporation-reports-fiscal-2023-second-quarter-results-and-raises-full-year-guidance/ 2022-11-01T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/McKesson_Logo-zuPYzv.jpeg https://medicaex.com/businesswire/michael-aldridge-seasoned-biotech-executive-appointed-ceo-of-focal-medical/ 2022-11-01T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Michael_Aldridge_CU-VncK3E.jpeg https://medicaex.com/businesswire/agilent-to-announce-fourth-quarter-fiscal-year-2022-financial-results-nov-21/ 2022-11-01T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Agilent-ce2oZi.jpeg https://medicaex.com/businesswire/bioelectronic-medicine-company-boomerang-medical-raises-15m-in-series-a-financing-2/ 2022-11-01T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Heather_Simonsen-qDwyr9.jpeg https://medicaex.com/businesswire/the-worldwide-blood-culture-test-industry-is-expected-to-reach-7-1-billion-by-2027-researchandmarkets-com/ 2022-11-01T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-nzMxS5.jpeg https://medicaex.com/businesswire/global-bone-graft-and-substitutes-market-report-to-2027-featuring-depuy-synthes-wright-medical-technology-medtronic-and-stryker-among-others-researchandmarkets-com-2/ 2022-11-01T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6F95st.jpeg https://medicaex.com/businesswire/ixlayer-announces-formation-of-advisory-board-3/ 2022-11-01T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/ixlayer-advisory-board-3-lW1Fy3.jpeg https://medicaex.com/businesswire/global-bone-graft-and-substitutes-market-report-to-2027-featuring-depuy-synthes-wright-medical-technology-medtronic-and-stryker-among-others-researchandmarkets-com/ 2022-11-01T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Vp64le.jpeg https://medicaex.com/businesswire/bioelectronic-medicine-company-boomerang-medical-raises-15m-in-series-a-financing/ 2022-11-01T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Heather_Simonsen-3IpM0U.jpeg https://medicaex.com/businesswire/global-pharmaceutical-contract-manufacturing-market-report-2022-growing-need-for-state-of-the-art-processes-and-production-technologies-driving-sector-researchandmarkets-com/ 2022-11-01T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-MYE3qq.jpeg https://medicaex.com/businesswire/ixlayer-announces-formation-of-advisory-board-2/ 2022-11-01T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ixlayer-advisory-board-3-MdjT5t.jpeg https://medicaex.com/businesswire/ixlayer-announces-formation-of-advisory-board/ 2022-11-01T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/ixlayer-advisory-board-3-df2RZ5.jpeg https://medicaex.com/businesswire/2022-u-s-coagulation-testing-market-report-identify-and-evaluate-emerging-business-opportunities-researchandmarkets-com-3/ 2022-11-01T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-CCUMQ9.jpeg https://medicaex.com/businesswire/innovaccer-appoints-tg-ganeshan-as-chief-financial-officer/ 2022-11-01T17:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Portrait_1-qkEeBW.jpeg https://medicaex.com/businesswire/2022-u-s-coagulation-testing-market-report-identify-and-evaluate-emerging-business-opportunities-researchandmarkets-com-2/ 2022-11-01T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-4g0IlN.jpeg https://medicaex.com/businesswire/practice-interactive-bolsters-healthcare-innovation-across-tech-wellness-supplements-2/ 2022-11-01T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Intiva_Health_MAIN_2800229-wJz2rm.jpeg https://medicaex.com/businesswire/ai-commercial-use-cases-impact-analyses-and-growth-opportunities-in-clinical-genomics-integration-of-clinical-genomics-and-ai-will-lead-to-definitive-transformational-growth-in-the-next-decade-re/ 2022-11-01T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Npkiyz.jpeg https://medicaex.com/businesswire/modmed-fully-resolves-all-government-claims/ 2022-11-01T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ModMed_Logo_2022-nt12t5.jpeg https://medicaex.com/businesswire/2022-transcatheter-mitral-valve-implantation-tmvi-pipeline-report-identify-emerging-players-with-potentially-strong-product-portfolio-researchandmarkets-com-2/ 2022-11-01T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-4S3avy.jpeg https://medicaex.com/businesswire/opum-and-corflex-global-partner-to-deliver-remote-clinical-grade-knee-assessment-2/ 2022-11-01T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Corflex_x_Opum_Logo-wlo4xM.jpeg https://medicaex.com/businesswire/2022-u-s-coagulation-testing-market-report-identify-and-evaluate-emerging-business-opportunities-researchandmarkets-com/ 2022-11-01T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-7rDBiD.jpeg https://medicaex.com/businesswire/2022-transcatheter-mitral-valve-implantation-tmvi-pipeline-report-identify-emerging-players-with-potentially-strong-product-portfolio-researchandmarkets-com/ 2022-11-01T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TEzgqu.jpeg https://medicaex.com/businesswire/practice-interactive-bolsters-healthcare-innovation-across-tech-wellness-supplements/ 2022-11-01T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Intiva_Health_MAIN_2800229-TJJNag.jpeg https://medicaex.com/businesswire/opum-and-corflex-global-partner-to-deliver-remote-clinical-grade-knee-assessment/ 2022-11-01T17:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/Corflex_x_Opum_Logo-awZt4f.jpeg https://medicaex.com/businesswire/h-i-g-capital-completes-sale-of-taconic-biosciences-2/ 2022-11-01T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_HIGCapital-aEYDnF.jpeg https://medicaex.com/businesswire/biochips-global-market-report-2022-increase-in-adoption-of-next-generation-sequencing-drives-growth-researchandmarkets-com-2/ 2022-11-01T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KGbQ2O.jpeg https://medicaex.com/businesswire/kovina-therapeutics-receives-nih-grant-to-develop-human-papillomavirus-e6-inhibitors-to-treat-oropharyngeal-cancers-2/ 2022-11-01T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_for_press_releases-XplsME.jpeg https://medicaex.com/businesswire/stevanato-group-and-gerresheimer-ag-present-ez-fill-smart-a-new-and-innovative-ready-to-use-vial-platform-2/ 2022-11-01T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/EZ-fill_Smart_N26T-pellicola_mid-1eONqi.jpeg https://medicaex.com/businesswire/4-hour-virtual-seminar-on-master-class-for-the-hipaa-officer-protecting-patient-information-and-implementing-todays-privacy-security-and-breach-regulations-webinar-researchandmarkets-com/ 2022-11-01T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Gax9G7.jpeg https://medicaex.com/businesswire/lab-on-a-chip-market-report-2022-increasing-use-across-the-life-sciences-driving-growth-researchandmarkets-com/ 2022-11-01T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-dUMbqq.jpeg https://medicaex.com/businesswire/global-vision-care-market-report-2022-increase-in-screen-time-creating-eye-issues-and-boosting-demand-in-sector-researchandmarkets-com-2/ 2022-11-01T16:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-hlSCRH.jpeg https://medicaex.com/businesswire/h-i-g-capital-completes-sale-of-taconic-biosciences/ 2022-11-01T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_HIGCapital-c657mS.jpeg https://medicaex.com/businesswire/biochips-global-market-report-2022-increase-in-adoption-of-next-generation-sequencing-drives-growth-researchandmarkets-com/ 2022-11-01T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-NR4its.jpeg https://medicaex.com/businesswire/kovina-therapeutics-receives-nih-grant-to-develop-human-papillomavirus-e6-inhibitors-to-treat-oropharyngeal-cancers/ 2022-11-01T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_for_press_releases-zsFePi.jpeg https://medicaex.com/businesswire/stevanato-group-and-gerresheimer-ag-present-ez-fill-smart-a-new-and-innovative-ready-to-use-vial-platform/ 2022-11-01T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/EZ-fill_Smart_N26T-pellicola_mid-pABcVO.jpeg https://medicaex.com/businesswire/global-vision-care-market-report-2022-increase-in-screen-time-creating-eye-issues-and-boosting-demand-in-sector-researchandmarkets-com/ 2022-11-01T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-tM2AWA.jpeg https://medicaex.com/businesswire/global-single-use-assemblies-market-report-2022-rapid-implementation-and-low-risk-of-cross-contamination-driving-growth-researchandmarkets-com-2/ 2022-11-01T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-X0wog5.jpeg https://medicaex.com/businesswire/global-hla-typing-market-report-2022-increasing-number-of-organ-transplants-drives-growth-researchandmarkets-com/ 2022-11-01T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-PTkyhc.jpeg https://medicaex.com/businesswire/snapnurse-partners-with-kevala-to-streamline-per-diem-staffing-in-healthcare/ 2022-11-01T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Full_Primary403x_28129-h1Y3aY.jpeg https://medicaex.com/businesswire/health-and-housing-coalition-launches-first-ever-medical-respite-program-in-nebraska/ 2022-11-01T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cync_Health_Primary_CMYK-MMjkiv.jpeg https://medicaex.com/businesswire/first-patient-enrolled-in-reflow-medicals-deeper-reveal-ide-clinical-study/ 2022-11-01T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/spurtip-XwjlZ1.jpeg https://medicaex.com/businesswire/global-wearable-injectors-market-report-2022-reduced-need-for-painful-injections-and-overall-user-friendliness-drives-adoption-researchandmarkets-com/ 2022-11-01T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-PHiaiM.jpeg https://medicaex.com/businesswire/global-single-use-assemblies-market-report-2022-rapid-implementation-and-low-risk-of-cross-contamination-driving-growth-researchandmarkets-com/ 2022-11-01T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-d3sidF.jpeg https://medicaex.com/businesswire/bdo-usa-llp-expands-netsuite-capabilities-with-the-addition-of-adaptalogix-llc-3/ 2022-11-01T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/BDO_logo_logotype-sbH3Xs.jpeg https://medicaex.com/businesswire/synaps-dx-publishes-first-autopsy-confirmed-results-for-identifying-alzheimers-in-presence-of-other-co-morbid-pathologies-using-discerntm-test-3/ 2022-11-01T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/SYNAPS_DX_LOGO_COLOR_HORIZONTAL-Wvdzak.jpeg https://medicaex.com/businesswire/deepcell-expands-adoption-of-ai-powered-morphology-characterization-for-biological-researchers-announces-ucsf-and-tgen-as-first-installations-in-technology-access-program/ 2022-11-01T14:12:12+00:00 https://medicaex.com/businesswire/ieee-open-journal-of-engineering-in-medicine-and-biology-report-on-new-ai-tool-details-improved-colorectal-cancer-survival-rate-2/ 2022-11-01T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/IEEE_EMBS_Logo-DqldGs.jpeg https://medicaex.com/businesswire/elemeno-health-and-sturdy-memorial-launch-team-empowerment-app-to-support-the-nursing-workforce/ 2022-11-01T14:12:09+00:00 https://medicaex.com/businesswire/dental-ai-startup-pearl-named-to-inc-s-inaugural-power-partner-awards/ 2022-11-01T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pearl_logo-lvFOob.jpeg https://medicaex.com/businesswire/particle-health-introduces-adt-notifications-through-its-single-api-integration/ 2022-11-01T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/PARTICLE_01_LOGO_01-lAKm7k.jpeg https://medicaex.com/businesswire/topcon-offers-maestro2-oct-certification-course/ 2022-11-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Course-rvBwsp.jpeg https://medicaex.com/businesswire/ieee-open-journal-of-engineering-in-medicine-and-biology-report-on-new-ai-tool-details-improved-colorectal-cancer-survival-rate/ 2022-11-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/IEEE_EMBS_Logo-AKmPul.jpeg https://medicaex.com/businesswire/bdo-usa-llp-expands-netsuite-capabilities-with-the-addition-of-adaptalogix-llc-2/ 2022-11-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/BDO_logo_logotype-UtxiGE.jpeg https://medicaex.com/businesswire/global-endometrial-ablation-devices-market-analysis-report-2022-a-990-9-million-market-in-2021-forecasts-to-2028-researchandmarkets-com/ 2022-11-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-kQNeQq.jpeg https://medicaex.com/businesswire/synaps-dx-publishes-first-autopsy-confirmed-results-for-identifying-alzheimers-in-presence-of-other-co-morbid-pathologies-using-discerntm-test-2/ 2022-11-01T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/SYNAPS_DX_LOGO_COLOR_HORIZONTAL-WZp4Jf.jpeg https://medicaex.com/businesswire/akston-biosciences-announces-positive-interim-phase-ii-results-from-covid-universal-booster-vaccine-trial/ 2022-11-01T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Akston_logo-RnqHTn.jpeg https://medicaex.com/businesswire/synaps-dx-publishes-first-autopsy-confirmed-results-for-identifying-alzheimers-in-presence-of-other-co-morbid-pathologies-using-discerntm-test/ 2022-11-01T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/SYNAPS_DX_LOGO_COLOR_HORIZONTAL-jOJ7xp.jpeg https://medicaex.com/businesswire/merz-aesthetics-announces-teyana-taylor-as-new-xeomin-incobotulinumtoxina-brand-partner/ 2022-11-01T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/UMG-Xeomin_-_Teyana_-_Up-Close_-_60_-_Master-PmPTWI.jpeg https://medicaex.com/businesswire/bdo-usa-llp-expands-netsuite-capabilities-with-the-addition-of-adaptalogix-llc/ 2022-11-01T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/BDO_logo_logotype-OkWvmS.jpeg https://medicaex.com/businesswire/gilead-to-present-data-across-viral-hepatitis-and-liver-fibrosis-at-the-liver-meeting-2022-reinforcing-gilead-as-a-leader-in-addressing-treatment-needs-for-people-living-with-liver-disease-2/ 2022-11-01T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/GCP_Primarylarge_1-UOqQ6w.jpeg https://medicaex.com/businesswire/atec-to-participate-in-upcoming-investor-conferences-2/ 2022-11-01T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/informed_logo_on_white-XSSWvC.jpeg https://medicaex.com/businesswire/arima-genomics-presents-data-on-cancer-structural-variants-at-the-association-of-molecular-pathology-annual-meeting-2/ 2022-11-01T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/ArimaGenomics_Logo_FullColor-ZV2Sv2.jpeg https://medicaex.com/businesswire/benson-hill-management-to-participate-in-upcoming-investor-events/ 2022-11-01T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/MattDeanConference-YP76GR.jpeg https://medicaex.com/businesswire/global-bio-decontamination-market-trends-and-forecasts-2022-2027-researchandmarkets-com/ 2022-11-01T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-r4oGl4.jpeg https://medicaex.com/businesswire/fujidenolo-solutions-starts-limited-time-offer-of-special-price-for-sonicdicom-pacs-cloud-a-cloud-based-medical-image-management-system/ 2022-11-01T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_org-ELh1ZM.jpeg https://medicaex.com/businesswire/syntellis-launches-focus-pathway-a-claims-visualization-solution-that-transforms-healthcare-data-into-actionable-intelligence/ 2022-11-01T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Syntellis_Logo-2b9j5N.jpeg https://medicaex.com/businesswire/l-heath-sampson-confirmed-as-modivcares-president-and-chief-executive-officer/ 2022-11-01T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Modivcare_Primary-1200x600-903638b-9XLCCn.jpeg https://medicaex.com/businesswire/arima-genomics-presents-data-on-cancer-structural-variants-at-the-association-of-molecular-pathology-annual-meeting/ 2022-11-01T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ArimaGenomics_Logo_FullColor-wiypiq.jpeg https://medicaex.com/businesswire/envoy-medical-early-feasibility-study-of-breakthrough-fully-implanted-cochlear-implant-now-underway-2/ 2022-11-01T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Envoy_Medical-aPNg8J.jpeg https://medicaex.com/businesswire/atec-to-participate-in-upcoming-investor-conferences/ 2022-11-01T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/informed_logo_on_white-dCbAsD.jpeg https://medicaex.com/businesswire/envoy-medical-early-feasibility-study-of-breakthrough-fully-implanted-cochlear-implant-now-underway/ 2022-11-01T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Envoy_Medical-vLaPA1.jpeg https://medicaex.com/businesswire/purivitae-ventures-and-mts-announce-strategic-partnership-2/ 2022-11-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Purivitae-Horizontal-RGB-4rtgBE.jpeg https://medicaex.com/businesswire/curvafix-receives-fda-clearance-for-smaller-diameter-intramedullary-implant-for-pelvic-fracture-fixation/ 2022-11-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_CurvaFix_Device_7.5-BQkXQw.jpeg https://medicaex.com/businesswire/dexcom-partners-with-warriors-and-nonprofits-to-artfully-advocate-for-access-to-diabetes-care/ 2022-11-01T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/NDAM_News_Release_Photo-FW40cP.jpeg https://medicaex.com/businesswire/purivitae-ventures-and-mts-announce-strategic-partnership/ 2022-11-01T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Purivitae-Horizontal-RGB-dXgDEt.jpeg https://medicaex.com/businesswire/global-pharmaceutical-rapid-microbiology-testing-markets-2020-2030-with-2021-as-the-base-year-researchandmarkets-com/ 2022-11-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-uTbWHT.jpeg https://medicaex.com/businesswire/gilead-to-present-data-across-viral-hepatitis-and-liver-fibrosis-at-the-liver-meeting-2022-reinforcing-gilead-as-a-leader-in-addressing-treatment-needs-for-people-living-with-liver-disease/ 2022-11-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/GCP_Primarylarge_1-9x9nUv.jpeg https://medicaex.com/businesswire/horizon-therapeutics-plc-named-to-the-seramount-inclusion-index/ 2022-11-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Horizon_Logo_Full-Color_RGB_Registered_Logo-HkTmIU.jpeg https://medicaex.com/businesswire/worldwide-acne-treatment-industry-to-2028-by-treatment-treatment-modality-end-users-and-region-researchandmarkets-com/ 2022-11-01T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-8nDGHc.jpeg https://medicaex.com/businesswire/teon-therapeutics-announces-first-patient-treated-in-phase-1-2-clinical-trial-of-tt-816-a-novel-oral-immune-checkpoint-inhibitor-in-patients-with-advanced-solid-tumors-2/ 2022-11-01T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/TEON_Logo_2022-MtCn54.jpeg